Madeline Smith, | |
120 Whitehall Blvd, Garden City, NY 11530-2726 | |
(516) 712-7036 | |
Not Available |
Full Name | Madeline Smith |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 120 Whitehall Blvd, Garden City, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003502246 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Madeline Smith, 120 Whitehall Blvd, Garden City, NY 11530-2726 Ph: (516) 712-7036 | Madeline Smith, 120 Whitehall Blvd, Garden City, NY 11530-2726 Ph: (516) 712-7036 |
News Archive
Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has expanded its plans for its United States Food and Drug Administration (FDA) Expanded Access Treatment IND Program for its flagship product, Generex Oral-lyn™, to include licensed and qualified Nurse Practitioners in the United States.
At the Center for Brain Research at the MedUni Vienna an important factor for stress has been identified in collaboration with the Karolinska Institutet in Stockholm (Sweden). This is the protein secretagogin that plays an important role in the release of the stress hormone CRH and which only then enables stress processes in the brain to be transmitted to the pituitary gland and then onwards to the organs.
The first few patients have received doses of an experimental RNA-targeting drug for Huntington's disease, it was announced today.
› Verified 7 days ago
Marisa Lant, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz, Garden City, NY 11530 Phone: 516-747-9030 | |
Maureen Dorothy Bock Murphy, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz, Suite 350, Garden City, NY 11530 Phone: 516-747-9030 | |
Tracy Needham, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 585 Stewart Ave, Garden City, NY 11530 Phone: 516-627-3036 | |
North Shore Center For Speech, Language & Swallowing Disorders Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 585 Stewart Ave, Suite 310, Garden City, NY 11530 Phone: 516-627-3036 Fax: 516-627-6741 | |
Alexis Thomas, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Garden City Plz Ste 350, Garden City, NY 11530 Phone: 516-747-9030 | |
Lori Hand, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 Roosevelt St, Garden City, NY 11530 Phone: 516-437-5402 |